PAIN
Volume 139, Issue 2 , Pages 293-305 , 15 October 2008

Ralfinamide administered orally before hindpaw neurectomy or postoperatively provided long-lasting suppression of spontaneous neuropathic pain-related behavior in the rat

  • Shi-Hong Zhang

      Affiliations

    • Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou, PR China
    • Centre for the Study of Pain, Faculties of Dentistry and Medicine, University of Toronto, 124 Edward Street, Toronto, Ont., Canada M5G 1G6
    • ,
  • Yotam Blech-Hermoni

      Affiliations

    • Centre for the Study of Pain, Faculties of Dentistry and Medicine, University of Toronto, 124 Edward Street, Toronto, Ont., Canada M5G 1G6
    • National Human Genome Research Institute, NIH, Bethesda, MD, USA
    • ,
  • Laura Faravelli

      Affiliations

    • Discovery Department, Newron Pharmaceuticals SpA, Bresso (MI), Italy
    • ,
  • Ze’ev Seltzer

      Affiliations

    • Centre for the Study of Pain, Faculties of Dentistry and Medicine, University of Toronto, 124 Edward Street, Toronto, Ont., Canada M5G 1G6
    • Corresponding Author InformationCorresponding author. Tel.: +1 416 979 4900x4433; fax: +1 416 979 4936.

Received 29 June 2007 ,Revised 18 April 2008 ,Accepted 24 April 2008.

References 

  1. Azkue JJ, Zimmermann M, Hsieh TF, Herdegen T. Peripheral nerve insult induces NMDA receptor-mediated, delayed degeneration in spinal neurons. Eur J Neurosci. 1998;10:2204–2206
  2. Baik-Han EJ, Kim KJ, Chung JM. Prolonged ongoing discharges of sensory nerves as recorded in isolated nerves in the rat. J Neurosci Res. 1990;27:219–227
  3. Basbaum AI. Effects of central lesions on disorders produced by multiple dorsal rhizotomy in rats. Exp Neurol. 1974;42:490–501
  4. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B. 1995;57:289–300
  5. Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann Stat. 2001;29:1165–1188
  6. Blumenkopf B, Lipman JJ. Studies in autotomy: its pathophysiology and usefulness as a model of chronic pain. Pain. 1991;45:203–209
  7. Challapalli V, Tremont-Lukats I, McNicol E, Lau J, Carr D, Tremont-Lukats I. Systemic administration of local anesthetic agents to relieve neuropathic pain. Cochrane Database Syst Rev. 2005;4:CD003345
  8. Cohn S, Seltzer Z. Inherited propensity for neuropathic pain is mediated by sensitivity to injury discharge. Neuroreport. 1991;2:647–650
  9. Colombo E, Curatolo L, Caccia C, Salvati P, Faravelli L. Ralfinamide acts through NMDA receptor complex: a central role for chronic pain treatment. Euro J Pain. 2007;11(Suppl. 1):152–153
  10. Dekker LV, Daniels Z, Hick C, Elsegood K, Bowden S, Szestak T, et al. Analysis of human Nav1. 8 expressed in SH-SY5Y neuroblastoma cells. Eur J Pharmacol. 2005;528:52–58
  11. Devor M. Strategies for finding new pharmacological targets for neuropathic pain. Curr Pain Headache Rep. 2004;8:187–191
  12. Devor M, Raber P. Autotomy after nerve injury and its relation to spontaneous discharge originating in nerve-end neuromas. Behav Neurol Biol. 1983;37:276–283
  13. Devor M, Raber P. Heritability of symptoms in an experimental model of neuropathic pain. Pain. 1990;42:51–67
  14. Devor M, Seltzer Z. Pathophysiology of damaged nerve and neuropathic pain. In:  Wall PD,  Melzack R editor. Textbook of pain. 4th ed.. NY: Churchill Livingstone; 1999;p. 129–161
  15. Devor M, Wall PD, Catalan N. Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction. Pain. 1992;48:261–268
  16. Duckrow RB, Taub A. The effect of diphenylhydantoin on self-mutilation in rats produced by unilateral multiple dorsal rhizotomy. Exp Neurol. 1977;54:33–41
  17. Gonzalez-Darder JM, Barbera J, Abellan MJ. Effects of prior anaesthesia on autotomy following sciatic transection in rats. Pain. 1986;24:87–91
  18. Hewitt KE, Stys PK, Lesiuk HJ. The use-dependent sodium channel blocker mexiletine is neuroprotective against global ischemic injury. Brain Res. 2001;898:281–287
  19. Inoue K, Tsuda M, Koizumi S. Chronic pain and microglia: the role of ATP. Novartis Found Symp. 2004;261:55–64
  20. Izzo E, Veneroni O, Graziani G, Paudice P, Raiteri M, Salvati P. Anti-inflammatory effect of ralfinamide on carraggeenan-induced paw oedema in rat and on spinal cord synaptosomes substance P release. Society for neuroscience, 34th annual meeting, San Diego, CA, USA; 2004.
  21. Lombard MC, Nashold BS, Albe-Fessard D, Salman N, Sakr C. Deafferentation hypersensitivity in the rat after dorsal rhizotomy: a possible animal model of chronic pain. Pain. 1979;6:163–174
  22. Matzner O, Devor M. Hyperexcitability at sites of nerve injury depends on voltage-sensitive Na+ channels. J Neurophysiol. 1994;72:349–359
  23. Michaelis M, Liu X, Janig W. Axotomized and intact muscle afferents but no skin afferents develop ongoing discharges of dorsal root ganglion origin after peripheral nerve lesion. J Neurosci. 2000;20:2742–2748
  24. Moore KA, Kohno T, Karchewski LA, Scholz J, Baba H, Woolf CJ. Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. J Neurosci. 2002;22:6724–6731
  25. Polgar E, Hughes DI, Riddell JS, Maxwell DJ, Puskar Z, Todd AJ. Selective loss of spinal GABAergic or glycinergic neurons is not necessary for development of thermal hyperalgesia in the chronic constriction injury model of neuropathic pain. Pain. 2003;104:229–239
  26. Priest BT, Kaczorowski GJ. Blocking sodium channels to treat neuropathic pain. Expert Opin Ther Targets. 2007;11:291–306
  27. Raber P, Devor M. Social variables affect phenotype in the neuroma model of neuropathic pain. Pain. 2002;97:139–150
  28. Sabsovich I, Neumann S, Dorfman R, Storm-Mathisen J, Ottersen OP, Raber P, Zeltser R, Devor M, Seltzer Z. Spinal dorsal horn inhibitory amino acid neurons: genetic differences and response to peripheral neurectomy. 3rd Congress of the European Federation of IASP Chapters (EFIC), Nice, France; 2000.
  29. Sackstein M, Ratner A, Seltzer Z. Specific patterns of injury discharge are associated with receptor types in freshly injured sensory myelinated (A-) and unmyelinated (C-) fibers in rat. 8th Congress of the International Association for the Study of Pain, Vancouver Canada; 1996.
  30. Seltzer Z, Beilin BZ, Ginzburg R, Paran Y, Shimko T. The role of injury discharge in the induction of neuropathic pain behavior in rats. Pain. 1991;46:327–336
  31. Seltzer Z, Cohn S, Ginzburg R, Beilin B. Modulation of neuropathic pain behavior in rats by spinal disinhibition and NMDA receptor blockade of injury discharge. Pain. 1991;45:69–75
  32. Seltzer Z, Paran Y, Eisen A, Ginzburg R. Neuropathic pain behavior in rats depends on the afferent input from nerve-end neuroma including histamine-sensitive C-fibers. Neurosci Lett. 1991;128:203–206
  33. Seltzer Z, Ratner A, Shir Y. Diet can modify autotomy behavior in rats following peripheral neurectomy. Neurosci Lett. 1997;236:71–74
  34. Seltzer Z, Tal M, Sharav Y. Autotomy behavior in rats following peripheral deafferentation is suppressed by daily injections of amitriptyline, diazepam and saline. Pain. 1989;37:245–250
  35. Seltzer Z. Zhang SH. Blech-Hermoni Y. Faravelli L. The novel analgesic ralfinamide differentially shuts off ectopic spontaneous firing in rat sciatic neuroma afferents without affecting normal nerve conduction. Society for Neuroscience 36th annual meeting. Atlanta, GA, USA; 2006.
  36. Shir Y, Zeltser R, Vatine JJ, Carmi G, Belfer I, Zangen A, et al. Correlation of intact sensibility and neuropathic pain-related behaviors in eight inbred and outbred rat strains and selection lines. Pain. 2001;90:75–82
  37. Stummann TC, Salvati P, Fariello RG, Faravelli L. The anti-nociceptive agent ralfinamide inhibits tetrodotoxin-resistant and tetrodotoxin-sensitive Na+ currents in dorsal root ganglion neurons. Eur J Pharmacol. 2005;510:197–208
  38. Sutherland S. Glia emerge as pain therapy targets. Drug Discov Today. 2004;9:588
  39. Veneroni O, Maj R, Calabresi M, Faravelli L, Fariello RG, Salvati P. Anti-allodynic effect of NW-1029, a novel Na(+) channel blocker, in experimental animal models of inflammatory and neuropathic pain. Pain. 2003;102:17–25
  40. Wall PD, Devor M, Inbal R, Scadding JW, Schonfeld D, Seltzer Z, et al. Autotomy following peripheral nerve lesions: experimental anaesthesia dolorosa. Pain. 1979;7:103–111
  41. Wall PD, Waxman S, Basbaum AI. Ongoing activity in peripheral nerve: injury discharge. Exp Neurol. 1974;45:576–589
  42. Watkins LR, Maier SF. Glia: a novel drug discovery target for clinical pain. Nat Rev Drug Discov. 2003;2:973–985
  43. Wieseler-Frank J, Maier SF, Watkins LR. Glial activation and pathological pain. Neurochem Int. 2004;45:389–395
  44. Wiesenfeld Z, Hallin RG. Influence of nerve lesions, strain differences and continuous cold stress on chronic pain behavior in rats. Physiol Behav. 1981;27:735–740
  45. Zeltser R, Seltzer Z, Eisen A, Feigenbaum JJ, Mechoulam R. Suppression of neuropathic pain behavior in rats by a non-psychotropic synthetic cannabinoid with NMDA receptor-blocking properties. Pain. 1991;47:95–103
  46. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 1983;16:109–110

PII: S0304-3959(08)00229-7

doi: 10.1016/j.pain.2008.04.020

PAIN
Volume 139, Issue 2 , Pages 293-305 , 15 October 2008

Article Tools

* Image Usage & Resolution